Because treatment with cytotoxic chemotherapy and radiotherapy indicated the increased FSH levels and reduced sperm counts, the effects of suppression of testosterone and gonadotrophin analogs on stimulation of spermatogonial differentiation, resulting in spermatogenic progression after cancer treatment, have been well demonstrated [99,100]. Here, BRD2 is linked to cancer.